Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20594918rdf:typepubmed:Citationlld:pubmed
pubmed-article:20594918lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:20594918lifeskim:mentionsumls-concept:C0026769lld:lifeskim
pubmed-article:20594918lifeskim:mentionsumls-concept:C0021756lld:lifeskim
pubmed-article:20594918lifeskim:mentionsumls-concept:C0376249lld:lifeskim
pubmed-article:20594918lifeskim:mentionsumls-concept:C2924423lld:lifeskim
pubmed-article:20594918lifeskim:mentionsumls-concept:C0018591lld:lifeskim
pubmed-article:20594918pubmed:issue1lld:pubmed
pubmed-article:20594918pubmed:dateCreated2010-9-17lld:pubmed
pubmed-article:20594918pubmed:abstractTextWe have evaluated the role of the HLA-DRB1*1501 allele and the IL-2 -330 T/G polymorphism and their interaction in susceptibility to multiple sclerosis on 360 patients and 426 matched healthy individuals. We used the SSP-PCR method to determine the alleles. Fisher's exact test was used to analyses. We observed a significant increase in the T allele at IL-2 -330 position in patients (OR=1.34, P<0.05), and the T/T and T/G genotypes were more frequent among patients than controls. The HLA-DRB1*1501 allele was overrepresented in patients as compared to the control group (OR=1.7, P=0.0006). The two-locus analysis of the interaction between the IL-2 promoter polymorphism and the HLA-DRB1 allele showed that the HLA-DRB1*1501/T haplotype was more frequent in patients than controls (OR=16, P<0.0001). Our findings support previous findings about the role of the HLA-DRB1*1501 allele in susceptibility to MS. This work also provides new findings about the importance of gene-gene interactions in the development of MS.lld:pubmed
pubmed-article:20594918pubmed:languageenglld:pubmed
pubmed-article:20594918pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20594918pubmed:citationSubsetIMlld:pubmed
pubmed-article:20594918pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20594918pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20594918pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20594918pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20594918pubmed:statusMEDLINElld:pubmed
pubmed-article:20594918pubmed:monthOctlld:pubmed
pubmed-article:20594918pubmed:issn1521-7035lld:pubmed
pubmed-article:20594918pubmed:authorpubmed-author:ShahbaziMajid...lld:pubmed
pubmed-article:20594918pubmed:authorpubmed-author:ZamaniMahdiMlld:pubmed
pubmed-article:20594918pubmed:authorpubmed-author:RoshandelDani...lld:pubmed
pubmed-article:20594918pubmed:authorpubmed-author:ShahbaziSaleh...lld:pubmed
pubmed-article:20594918pubmed:authorpubmed-author:EbadiHamidHlld:pubmed
pubmed-article:20594918pubmed:authorpubmed-author:FathiDavoodDlld:pubmed
pubmed-article:20594918pubmed:authorpubmed-author:BoghaeeMojdeh...lld:pubmed
pubmed-article:20594918pubmed:authorpubmed-author:Mohammadhosee...lld:pubmed
pubmed-article:20594918pubmed:authorpubmed-author:RshaidbaghanA...lld:pubmed
pubmed-article:20594918pubmed:authorpubmed-author:BakhshandehAz...lld:pubmed
pubmed-article:20594918pubmed:copyrightInfoCopyright © 2010 Elsevier Inc. All rights reserved.lld:pubmed
pubmed-article:20594918pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20594918pubmed:volume137lld:pubmed
pubmed-article:20594918pubmed:ownerNLMlld:pubmed
pubmed-article:20594918pubmed:authorsCompleteYlld:pubmed
pubmed-article:20594918pubmed:pagination134-8lld:pubmed
pubmed-article:20594918pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:20594918pubmed:meshHeadingpubmed-meshheading:20594918...lld:pubmed
pubmed-article:20594918pubmed:meshHeadingpubmed-meshheading:20594918...lld:pubmed
pubmed-article:20594918pubmed:meshHeadingpubmed-meshheading:20594918...lld:pubmed
pubmed-article:20594918pubmed:meshHeadingpubmed-meshheading:20594918...lld:pubmed
pubmed-article:20594918pubmed:meshHeadingpubmed-meshheading:20594918...lld:pubmed
pubmed-article:20594918pubmed:meshHeadingpubmed-meshheading:20594918...lld:pubmed
pubmed-article:20594918pubmed:meshHeadingpubmed-meshheading:20594918...lld:pubmed
pubmed-article:20594918pubmed:meshHeadingpubmed-meshheading:20594918...lld:pubmed
pubmed-article:20594918pubmed:meshHeadingpubmed-meshheading:20594918...lld:pubmed
pubmed-article:20594918pubmed:meshHeadingpubmed-meshheading:20594918...lld:pubmed
pubmed-article:20594918pubmed:meshHeadingpubmed-meshheading:20594918...lld:pubmed
pubmed-article:20594918pubmed:meshHeadingpubmed-meshheading:20594918...lld:pubmed
pubmed-article:20594918pubmed:meshHeadingpubmed-meshheading:20594918...lld:pubmed
pubmed-article:20594918pubmed:meshHeadingpubmed-meshheading:20594918...lld:pubmed
pubmed-article:20594918pubmed:meshHeadingpubmed-meshheading:20594918...lld:pubmed
pubmed-article:20594918pubmed:meshHeadingpubmed-meshheading:20594918...lld:pubmed
pubmed-article:20594918pubmed:meshHeadingpubmed-meshheading:20594918...lld:pubmed
pubmed-article:20594918pubmed:year2010lld:pubmed
pubmed-article:20594918pubmed:articleTitleHigh frequency of the IL-2 -330 T/HLA-DRB1*1501 haplotype in patients with multiple sclerosis.lld:pubmed
pubmed-article:20594918pubmed:affiliationMedical Cellular & Molecular Research Center, Talghani Children Hospital of Golestan University of Medical Sciences, Bolv Janbazan, 4916668197, Gorgan, Iran. shahbazimajid@yahoo.co.uklld:pubmed
pubmed-article:20594918pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20594918pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:3123entrezgene:pubmedpubmed-article:20594918lld:entrezgene
entrez-gene:3558entrezgene:pubmedpubmed-article:20594918lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:20594918lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:20594918lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:20594918lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:20594918lld:entrezgene